| Date | Time | Source | Headline | Symbol | Company |
| 10/15/2012 | 6:02AM | Edgar (US Regulatory) | Voluntary supplemental material filed pursuant to Section 11(a) of the Securities Act of 1933 by foreign issuers (SUPPL) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/12/2012 | 5:25PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/12/2012 | 8:55AM | PR Newswire (US) | Aeterna Zentaris Announces Pricing of US$16.5 Million Public Offering of Common Shares and Warrants | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/12/2012 | 6:55AM | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/12/2012 | 6:02AM | Edgar (US Regulatory) | Voluntary supplemental material filed pursuant to Section 11(a) of the Securities Act of 1933 by foreign issuers (SUPPL) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/11/2012 | 4:13PM | PR Newswire (US) | Aeterna Zentaris Announces Proposed Public Offering of Common Shares and Warrants | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/10/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris: Phase 3 Results for AEZS-130 in AGHD to be Presented at Upcoming GRS and IGF Society Congress | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/03/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris Announces Share Consolidation to Regain NASDAQ Compliance | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/02/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris Presented Poster on Oral Prostate Cancer Vaccine, AEZS-120, at International Urology Conference in Japan | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 09/28/2012 | 8:20AM | Marketwired | Biotech Industry Look to Benefit From the Introduction of the High Technology Small Business Research Incentives Act | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 09/26/2012 | 2:30PM | PR Newswire (US) | Aeterna Zentaris Provides Update on NDA Filing for AEZS-130 as Diagnostic Test for Adult Growth Hormone Deficiency | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 09/26/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris to Present at BioContact in Québec City | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 09/25/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris Granted Patent by European Patent Office for AEZS-130 in Growth Hormone Deficiency Diagnosis | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 09/20/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris to Present Poster on Oral Prostate Cancer Vaccine Candidate, AEZS-120, at Upcoming International Urology Con... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 09/12/2012 | 8:20AM | Marketwired | Faster Approval Process Contributing to Biotech Industry's Success in 2012 | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 09/05/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris to Present at Rodman & Renshaw 14th Annual Global Investment Conference in New York | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 08/29/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris to Present at Stifel Nicolaus Healthcare Conference in Boston | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 08/28/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris Announces First Patient Recruited for Phase 2A Trial in Cancer Cachexia with AEZS-130 | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 08/17/2012 | 8:20AM | Marketwired | M&A Activity in the Biotech Industry at a Four-Year High as Large Pharmaceuticals Look to Replace Lose Revenues | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 08/15/2012 | 11:40AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 08/14/2012 | 4:34PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 08/14/2012 | 4:32PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 08/14/2012 | 4:30PM | PR Newswire (US) | Aeterna Zentaris Reports Second Quarter 2012 Financial and Operating Results | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 08/13/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris to Present Preclinical Data for PI3K/Erk 1/2 Inhibitor, AEZS-136, at ACS National Meeting | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 08/09/2012 | 3:58PM | Business Wire | UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in AEterna Zentaris, Inc. of Class Act... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 08/08/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris to Announce Second Quarter 2012 Financial and Operating Results on August 14, 2012 | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 08/07/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris Granted Patent in the U.S. for AEZS-130 as Diagnostic Test for Adult Growth Hormone Deficiency | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 08/06/2012 | 6:00PM | PR Newswire (US) | Faruqi & Faruqi, LLP Notifies Investors Who Suffered Substantial Losses Investing In AEterna Zentaris Inc. of Upcoming August... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 08/02/2012 | 3:34PM | GlobeNewswire Inc. | UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in AEterna Zentaris, Inc. of Class Actio | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 07/26/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris: Preclinical Data for AEZS-108 in Bladder Cancer Published Online in Oncotarget | NASDAQ:AEZS | Aeterna Zentaris Inc |